{"id":"W4406701803","doi":"10.1016/j.pharmr.2025.100042","title":"Cyclic nucleotide phosphodiesterases as drug targets","year":2025,"lang":"en","type":"review","venue":"Pharmacological Reviews","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Eye Institute; National Institute on Aging; Helse Sør-Øst RHF; Canadian Institutes of Health Research; Manchester Biomedical Research Centre; NIHR Oxford Biomedical Research Centre; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Agence Nationale de la Recherche; National Multiple Sclerosis Society; Deutsche Forschungsgemeinschaft; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; British Heart Foundation; Natural Sciences and Engineering Research Council of Canada; Health~Holland; National Institutes of Health; Smart Family Foundation; Novartis; Kreftforeningen; Foundation for Cardiovascular Research","keywords":"Phosphodiesterase; Nucleotide; Drug; Cyclic nucleotide; Cyclic nucleotide phosphodiesterase; Chemistry; Pharmacology; Computational biology; Biochemistry; Cell biology; Biology; Enzyme; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004047104,0.0004857951,0.0007432313,0.0007348449,0.000222043,0.001047122,0.000527743,0.001036726,0.008334383],"category_scores_gemma":[0.000540976,0.0001672367,0.000500861,0.000565581,0.0002909648,0.000933848,0.0005773971,0.001726438,0.003612026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005699206,"about_ca_system_score_gemma":0.0006512115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005544281,"about_ca_topic_score_gemma":0.001291712,"domain_scores_codex":[0.999788,0.00004487903,0.00001867019,0.00004456921,0.0000689796,0.00003490719],"domain_scores_gemma":[0.9998505,0.00004605691,0.00002101113,0.000007692332,0.00005191698,0.0000228164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005129155,0.0002880917,0.0006725049,0.01341614,0.0001963133,0.0009093058,0.0001509116,0.001611405,0.05134438,0.02666682,0.07326393,0.8309672],"study_design_scores_gemma":[0.0000950363,0.0004080082,0.0009332994,0.001308896,0.0001413469,0.001283187,0.00005559873,0.0005852577,0.01084152,0.005000542,0.9793141,0.00003324019],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003110684,0.9794071,0.00206114,0.00286399,0.0009198211,0.00004275016,0.000366487,0.00009691103,0.01113115],"genre_scores_gemma":[0.03094296,0.9521227,0.002521036,0.002254721,0.0009126932,0.00008117177,0.0007557124,0.00002906622,0.01037993],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008334383,"threshold_uncertainty_score":0.02788126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04384731252438048,"score_gpt":0.3880629043917895,"score_spread":0.344215591867409,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}